Caplin Point Laboratories Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Chairman
Chairman
Caplin Point Laboratories Limited
Equibles does not estimate personal net worth.
C.C. Partipan is recorded as Chairman at Caplin Point Laboratories Limited. C.C. Partipan has spoken on 3 earnings calls across 1 company, most recently for Caplin Point Laboratories Limited on November 12, 2026. Caplin Point Laboratories Limited is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
“The two important works of our business are build and sustain. Get grit and gumption to build unique model, systems and standards to sustain. We are also aware that processes does not live in people's head.”
“When everyone said Kaplan was no more, we proved that we are now here. You know, ours is a turnaround story. Today, we are neither a parrot that talks too much, but can't fly, nor an eagle, which has the power to touch the sky.”
“Let me first lift out the differentiation that we have created in the last five years. Revenue doubles from 1,085 crore to 2,300 crore in 2526. Liquid assets tripled 928 crore to 2,726 crore.”
Caplin Point Laboratories Limited
Chairman
Transcript header (unverified)
Caplin Point Laboratories Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Chairman
Earnings Call for the Quarter Ended September 30, 2026
Caplin Point Laboratories Limited
Earnings Call for the Quarter Ended June 30, 2026
Caplin Point Laboratories Limited
Earnings Call for the Quarter Ended March 31, 2026
Caplin Point Laboratories Limited